LUNG Pulmonx Corp. Quarterly Revenue Growth

Pulmonx (LUNG) - corporate logo

The aggressive expansion of Zephyr system sales across US clinics is driving demand for emphysema therapy, rendering the Pulmonx Corporation (LUNG) business resilient to crises. Quarterly sales volume growth confirms this trend, where 6.40 represents the current level of the metric. Process stability is further bolstered by the recruitment of top-tier engineers and medical professionals developing innovative lung treatment solutions.

LUNG (Pulmonx Corp.) Quarterly Sales Growth Rate history from 07/04/2022 to 11/21/2026

Summary analytical data breakdowns for Pulmonx Corporation (LUNG)

- stock price and consensus target price:
Fundamental company valuation:Pulmonx Corp. - LUNG
Manufactured products of Pulmonx Corp.

Investors use this indicator to assess business scaling rates and the ability of Pulmonx Corporation (LUNG) to outperform its own historical results. The metric measures the percentage deviation of current revenues from the same period last year, while quarterly revenue dynamics confirm the effectiveness of Pulmonx Corporation (LUNG) medical logistics in ensuring the seamless delivery of systems and consumables to clinics.

Competing companies

DexCom Inc - Quarterly Revenue Growth|PEN (Penumbra, Inc.) - Sales Growth QoQ|NOVT: Quarterly Revenue Growth|HAE - Quarterly Sales Growth Rate|INSP (Inspire Medical Systems Inc) - Quarterly Revenue Growth|PROCEPT BioRobotics Inc (PRCT) - Quarterly Sales Growth Rate|Quarterly Revenue Growth CNMD|Quarterly Sales Growth Pulse Biosciences, Inc. PLSE|Quarterly Revenue Growth INMD (inmodemd.com)|Picard Medical Inc. - Revenue Growth QoQ|SRDX - Revenue Growth QoQ|SENS: Revenue Growth QoQ|NPCE (NeuroPace, Inc.) - Quarterly Sales Growth|Tactile Systems Technology, Inc. - Quarterly Revenue Increase|SNWV (SANUWAVE Health Inc) - Quarterly Revenue Growth|Quarterly Revenue Growth Outset Medical|Revenue Growth QoQ Electromed (ELMD)|LENSAR, Inc. (LNSR) - Revenue Change vs Previous Quarter|AVITA Medical Inc - Quarterly Sales Growth|Quarterly Revenue Growth Profound Medical Corporation PROF|Baird Medical Investment Holdings - Quarterly Revenue Growth|Quarterly Sales Growth Rate EDAP TMS EDAP|Apyx Medical Corporation (APYX) - Revenue Growth QoQ|Revenue Dynamics QoQ ICCM (IceCure Medical, Ltd.)|Revenue Growth QoQ telabio.com|Quarterly Sales Growth Cytosorbents (CTSO)|Quarterly Revenue Growth SRTS|ZYXI - Quarterly Revenue Growth Rate|Revenue Growth QoQ electrocore.com ECOR|RBOT: Sales Growth QoQ|IINN: Quarterly Sales Growth|Quarterly Sales Growth Rate SeaStar Medical Holding ICU|IRIX: Quarterly Revenue Growth|INBS - Quarterly Sales Growth Rate|XAIR (Beyond Air Inc) - Quarterly Revenue Growth|PFSA: Quarterly Revenue Increase|Revenue Growth QoQ STRATA Skin Sciences Inc. (SSKN)|Quarterly Revenue Growth GlucoTrack, Inc. (GCTK)|Revenue Growth QoQ nanovibronix.com NAOV|Quarterly Revenue Growth Venus Concept Inc VERO|NUWE - Revenue Growth QoQ|AEMD: Revenue Growth QoQ|ASXC (Asensus Surgical) - Quarterly Sales Growth|Quarterly Revenue Growth Rate avinger.com (AVGR)|Quarterly Sales Growth BSGM|CUTR: Quarterly Revenue Increase|Revenue Growth QoQ Know Labs Corporation (KNW)|NARI - Quarterly Revenue Growth Rate|Revenue Growth QoQ Nevro Corp. NVRO|ReShape Lifesciences Inc - Revenue Growth QoQ|SILK: Quarterly Sales Growth